Press Release Archives*

2007

November 28, 2007 (PDF)
Binex and MaxCyte Collaborate on Cancer Immunotherapy Research
August 27, 2007 (PDF)
Medinet Licenses MaxCyte Cell Loading Technology For Cancer Immunotherapy in Japan
June 22, 2007 (PDF)
MaxCyte and Medinet to present at the 13th Annual Meeting of the International Society for Cellular Therapy (ISCT) in Sydney, Australia
June 20, 2007 (PDF)
MaxCyte To Present at BIOTECH CHINA 2007
June 13, 2007 (PDF)
MaxCyte to Speak at TERMIS North America 2007 Conference & Exposition
May 29, 2007 (PDF)
MaxCyte to Present at American Society for Gene Therapy (ASGT) 10th Annual Meeting
May 4, 2007 (PDF)
MaxCyte Announces Appointment of Douglas A Doerfler to BIO's Board of Directors
May 3, 2007 (PDF)
MaxCyte Organizes Stem Cell Session at BIO 2007 - "Delivering the Promise of Stem Cell Therapeutics"
April 25, 2007 (PDF)
MaxCyte to Speak at European Stem Cell & Regenerative Medicine Congress 2007 - "Potentiating the Therapeutic Effect of Stem Cell Product"
March 22, 2007 (PDF)
MaxCyte to be Featured Speaker at the Keystone Symposia: The Potent New Anti-Tumor Immunotherapies
February 26, 2007 (PDF)
MaxCyte to Present at BIO-Europe Spring 2007
February 8, 2007 (PDF)
MaxCyte to be Featured Speaker at the 2nd Annual Stem Cell Summit
February 7, 2007 (PDF)
MaxCyte to Present at the BIO CEO & Investor Conference
January 30, 2007 (PDF)
MaxCyte to Present at the BioPartnering North America Conference
January 22, 2007 (PDF)
MaxCyte Technology Licensed For Use In Geron's Cancer Vaccines
January 18, 2007 (PDF)
Leading Researcher in Skeletal Tissue Engineering and Regeneration to Speak at the MaxCyte Lunch Briefing
January 17, 2007 (PDF)
MaxCyte to Sponsor Symposium at BIO Asia 2007
January 16, 2007 (PDF)
MaxCyte is a Featured Speaker at the 2nd International Stem Cells and Regenerative Medicine 2007
January 16, 2007 (PDF)
MaxCyte is a Featured Speaker at the Phacilitate Cell and Gene Therapy Forum 2007

You must have Adobe Acrobat Reader in order to view Press Releases. You can Download the latest version for free.